French Court of Appeal SPC decision raises validity concerns
Merck IP right fails test in latest Article 3(a) judgment in case that may make France an even more attractive venue for nullity actions
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.